Nu Skin Enterprises, Inc.
NUS
$8.48
-$0.09-1.05%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -14.26% | -12.10% | -11.79% | -11.85% | -12.04% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -14.26% | -12.10% | -11.79% | -11.85% | -12.04% |
| Cost of Revenue | -11.28% | 4.11% | -7.13% | -5.61% | -6.36% |
| Gross Profit | -15.50% | -17.68% | -13.69% | -14.29% | -14.22% |
| SG&A Expenses | -16.85% | -15.62% | -14.11% | -12.90% | -12.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.11% | -10.11% | -11.97% | -10.71% | -10.51% |
| Operating Income | 1.45% | -33.74% | -8.88% | -28.28% | -33.03% |
| Income Before Tax | 212.08% | 211.38% | 175.49% | -417.40% | -758.63% |
| Income Tax Expenses | 226.48% | 324.78% | 331.43% | -118.32% | -258.24% |
| Earnings from Continuing Operations | 209.28% | 206.20% | 167.92% | -1,063.13% | -1,805.57% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 209.28% | 206.20% | 167.92% | -1,063.13% | -1,805.57% |
| EBIT | 1.45% | -33.74% | -8.88% | -28.28% | -33.03% |
| EBITDA | -10.19% | -30.07% | -11.02% | -21.32% | -21.48% |
| EPS Basic | 209.55% | 206.29% | 167.96% | -1,080.00% | -1,795.46% |
| Normalized Basic EPS | 53.65% | 11.06% | 39.40% | -27.91% | -41.23% |
| EPS Diluted | 208.05% | 204.71% | 167.13% | -1,004.01% | -1,860.20% |
| Normalized Diluted EPS | 52.56% | 10.37% | 39.35% | -27.84% | -40.98% |
| Average Basic Shares Outstanding | -0.74% | -0.01% | 0.06% | 0.07% | -0.10% |
| Average Diluted Shares Outstanding | 0.69% | 0.71% | 0.36% | 0.21% | -0.44% |
| Dividend Per Share | 0.00% | -57.89% | -73.33% | -80.49% | -84.62% |
| Payout Ratio | 1.91% | 1.40% | 1.39% | 0.98% | -1.01% |